Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.920
+0.106 (3.77%)
May 18, 2026, 4:14 PM CET
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €218.12 million as of May 18, 2026. Its market cap has increased by 5.79% in one year.
Market Cap
218.12M
Enterprise Value
207.51M
Revenue
10.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.92
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 218.12M, an increase of 78.79%. That is a compound annual growth rate of 5.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 218.12M | -11.06% |
| Dec 31, 2025 | 245.23M | 170.69% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.57B |
| Laboratorios Farmaceuticos Rovi | 3.02B |
| Almirall | 2.43B |
| Pharma Mar | 1.67B |
| Clínica Baviera | 893.83M |
| Prim, S.A. | 221.18M |
| Laboratorio Reig Jofre | 220.63M |
| Atrys Health | 204.57M |